FDA.reportPublic FDA data

TLANDO 112.5 MG Oral Capsule

RxCUI
2599060
RxNorm name
TLANDO 112.5 MG Oral Capsule
Display name
TLANDO 112.5 MG Oral Capsule
Full name
TLANDO 112.5 MG Oral Capsule
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:38:57

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
TlandoTESTOSTERONE UNDECANOATEVerity Pharmaceuticals Inc.4b0b92e9-6d3c-a0e5-e1c7-342999f725802026-02-25Warnings, Adverse reactionsExact identifier
rxcui: 2599060

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
4b0b92e9-6d3c-a0e5-e1c7-342999f72580TLANDO 112.5 MG Oral Capsule [PSN] · testosterone undecanoate 112.5 MG Oral Capsule [Tlando] [SBD] · Tlando 112.5 MG Oral Capsule [SY]35These highlights do not include all the information needed to use TLANDO ® safely and effectively. See full prescribing information for TLANDO. TLANDO (testosterone undecanoate) capsules, for oral use, CIII Initial U.S. Approval: 195320260225